FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2067855145> ?p ?o ?g. }

• W2067855145 endingPage "2383" @default.
• W2067855145 startingPage "2375" @default.
• W2067855145 abstract "BACKGROUND. New developments in the treatment of patients with metastatic renal cell cancer (MRCC) have suggested a need to reevaluate the role of systemic therapies. The authors convened a panel of medical and urologic oncologists to rate the appropriateness of the main options. METHODS. The authors used the RAND/University of California-Los Angeles Appropriateness Method to evaluate systemic therapy options and cytoreductive nephrectomy. After a comprehensive literature review, an expert panel rated the appropriateness of systemic options (108 permutations) and cytoreductive nephrectomy (24 permutations) for patients with MRCC. RESULTS. The appropriateness evaluation indicated that 27.3% of permutations were rated “appropriate,” 46.9% were rated “inappropriate,” and 25.8% were rated “uncertain.” There was a high rate of agreement (95%). Sunitinib and sorafenib were rated appropriate for patients with low-to-moderate risk regardless of prior treatment. Temsirolimus was rated appropriate for first-line therapy for higher risk patients. Interferon-α and low-dose interleukin-2 were rated inappropriate or uncertain. In patients who received prior immunotherapy, cytokines were rated inappropriate. In all permutations for evaluating systemic therapy, enrollment into an investigational trial was considered appropriate, treatment with bevacizumab was uncertain, and thalidomide was inappropriate regardless of risk status or prior therapy. For good surgical risk patients with planned immunotherapy, nephrectomy was rated appropriate in patients who had limited metastatic burden regardless of tumor-related symptoms and in symptomatic patients regardless of metastatic burden. Only the most favorable combination of surgical risk, metastatic burden, and symptoms generated an “appropriate” rating for patients with planned targeted therapy. CONCLUSIONS. The current results begin the process of defining an appropriate role for cytokines, newer targeted therapies, and surgery in the treatment of MRCC. Cancer 2006. © 2006 American Cancer Society." @default.
• W2067855145 created "2016-06-24" @default.
• W2067855145 creator A5015274357 @default.
• W2067855145 creator A5017537551 @default.
• W2067855145 creator A5032420776 @default.
• W2067855145 creator A5038630213 @default.
• W2067855145 creator A5043554307 @default.
• W2067855145 creator A5050649350 @default.
• W2067855145 creator A5052526230 @default.
• W2067855145 creator A5072800302 @default.
• W2067855145 creator A5076705055 @default.
• W2067855145 creator A5082466279 @default.
• W2067855145 date "2006-01-01" @default.
• W2067855145 modified "2023-10-16" @default.
• W2067855145 title "Treatment of patients with metastatic renal cell cancer" @default.
• W2067855145 cites W1819301164 @default.
• W2067855145 cites W1865252469 @default.
• W2067855145 cites W1880480189 @default.
• W2067855145 cites W1893617912 @default.
• W2067855145 cites W1915939031 @default.
• W2067855145 cites W1928193662 @default.
• W2067855145 cites W1964988193 @default.
• W2067855145 cites W1966497667 @default.
• W2067855145 cites W1987426056 @default.
• W2067855145 cites W1996509713 @default.
• W2067855145 cites W2021256410 @default.
• W2067855145 cites W2036287010 @default.
• W2067855145 cites W2043393027 @default.
• W2067855145 cites W2046507292 @default.
• W2067855145 cites W2049689068 @default.
• W2067855145 cites W2050084558 @default.
• W2067855145 cites W2053364576 @default.
• W2067855145 cites W2072933160 @default.
• W2067855145 cites W2082331198 @default.
• W2067855145 cites W2085925464 @default.
• W2067855145 cites W2098136315 @default.
• W2067855145 cites W2098176107 @default.
• W2067855145 cites W2100557268 @default.
• W2067855145 cites W2106453307 @default.
• W2067855145 cites W2108945778 @default.
• W2067855145 cites W2112878358 @default.
• W2067855145 cites W2114271871 @default.
• W2067855145 cites W2116661424 @default.
• W2067855145 cites W2117838810 @default.
• W2067855145 cites W2132625873 @default.
• W2067855145 cites W2133157945 @default.
• W2067855145 cites W2143813821 @default.
• W2067855145 cites W2149660329 @default.
• W2067855145 cites W2171469612 @default.
• W2067855145 cites W2241421448 @default.
• W2067855145 cites W2305352133 @default.
• W2067855145 cites W2332704525 @default.
• W2067855145 cites W2334694951 @default.
• W2067855145 cites W2339429909 @default.
• W2067855145 cites W2513233117 @default.
• W2067855145 cites W2589956807 @default.
• W2067855145 cites W2595387994 @default.
• W2067855145 cites W2950942979 @default.
• W2067855145 cites W37165807 @default.
• W2067855145 cites W4244211158 @default.
• W2067855145 cites W4298379398 @default.
• W2067855145 cites W83138054 @default.
• W2067855145 cites W1979322890 @default.
• W2067855145 doi "https://doi.org/10.1002/cncr.22260" @default.
• W2067855145 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17048248" @default.
• W2067855145 hasPublicationYear "2006" @default.
• W2067855145 type Work @default.
• W2067855145 sameAs 2067855145 @default.
• W2067855145 citedByCount "63" @default.
• W2067855145 countsByYear W20678551452012 @default.
• W2067855145 countsByYear W20678551452013 @default.
• W2067855145 countsByYear W20678551452014 @default.
• W2067855145 countsByYear W20678551452015 @default.
• W2067855145 countsByYear W20678551452016 @default.
• W2067855145 countsByYear W20678551452017 @default.
• W2067855145 countsByYear W20678551452019 @default.
• W2067855145 countsByYear W20678551452022 @default.
• W2067855145 crossrefType "journal-article" @default.
• W2067855145 hasAuthorship W2067855145A5015274357 @default.
• W2067855145 hasAuthorship W2067855145A5017537551 @default.
• W2067855145 hasAuthorship W2067855145A5032420776 @default.
• W2067855145 hasAuthorship W2067855145A5038630213 @default.
• W2067855145 hasAuthorship W2067855145A5043554307 @default.
• W2067855145 hasAuthorship W2067855145A5050649350 @default.
• W2067855145 hasAuthorship W2067855145A5052526230 @default.
• W2067855145 hasAuthorship W2067855145A5072800302 @default.
• W2067855145 hasAuthorship W2067855145A5076705055 @default.
• W2067855145 hasAuthorship W2067855145A5082466279 @default.
• W2067855145 hasConcept C121608353 @default.
• W2067855145 hasConcept C126322002 @default.
• W2067855145 hasConcept C143998085 @default.
• W2067855145 hasConcept C177713679 @default.
• W2067855145 hasConcept C183713625 @default.
• W2067855145 hasConcept C185592680 @default.
• W2067855145 hasConcept C185926286 @default.
• W2067855145 hasConcept C190283241 @default.
• W2067855145 hasConcept C2776364478 @default.
• W2067855145 hasConcept C2776694085 @default.

• next